TIToshifumi Imagawa

Toshifumi Imagawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Toshifumi Imagawa has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Tetsuro Suzuki

    Department of Microbiology and Immunology, Hamamatsu University School of Medicine

    2 shared publications
  • Akira Muramatsu

    Department of Medical Virology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, 852-8523, Japan; Department of Laboratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, 852-8501, Japan

    1 shared publication
  • Chizuko Yaguchi

    Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine

    1 shared publication
  • Hidekazu Nishimura

    Virus Research Center, Clinical Research Division, Sendai Medical Center National Hospital Organization Sendai Japan

    1 shared publication
  • Hiroaki Itoh

    Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine

    1 shared publication
  • Isao Kosugi

    Department of Regenerative and Infectious Pathology, Hamamatsu University School of Medicine

    1 shared publication

Latest Publications

  • CRISPR-Cas12a biosensing via transcription of crRNA from PCR or LAMP products for pathogen detection

    by Patrick Wakaba, Akira Muramatsu, Toshifumi Imagawa, Yuki Furuse, Nobuo Saito, Naoki Uno


  • Open Access

    Pathological characterization of female reproductive organs prior to miscarriage induced by Zika virus infection in the pregnant common marmoset

    by Toshifumi Imagawa, Kazuo Tanaka, Masahiko Ito, Mami Matsuda, Tadaki Suzuki, Tsuyoshi Ando, Chizuko Yaguchi, Kazuyoshi Miyamoto, Shuji Takabayashi, Ryosuke Suzuki, et al.

    While Zika virus (ZIKV) infection in pregnant women is known to increase the risk of miscarriage and stillbirth, the mechanism by which ZIKV infection leads to the inability to continue a pregnancy is not clear. In our common marmoset models of ZIKV infection in pregnant individuals, miscarriage was observed in dams infected in the first or second trimester, and preterm delivery was observed in a dam infected in the third trimester. Serum progesterone levels were significantly lower prior to miscarriage or preterm delivery in the infected marmosets. To elucidate the pathology of the placental region just before the onset of ZIKV-induced miscarriage, we newly prepared an infected marmoset in the first trimester of pregnancy and euthanized it when the serum progesterone concentration was markedly reduced. Pathological analysis revealed significant degeneration in cells at the maternal-fetal interface, presumably trophoblasts. Cleaved-caspase was widely observed in the endometrial to placental region, and TNFα at 200 pg/mL was detected in the amniotic fluid, suggesting that apoptosis may progress in the endometrium and placenta, leading to decreased trophoblast function and miscarriage. ZIKV NS1 protein was found sporadically in the cellular degeneration area and widely in the basal layer of the endometrium. Furthermore, the viral protein was frequently detected in the follicles and corpus luteum of the ovary. The developed ZIKV infection model in pregnant marmosets would be useful not only to better understand the mechanism of ZIKV-induced miscarriage but also to analyze the effects of the viral infection on female reproductive tissues. IMPORTANCE: Although several viruses, including Zika virus (ZIKV), are known to increase the risk of miscarriage upon viral infection, the mechanism by which miscarriage is induced by viral infection is largely unknown. This is partly due to the difficulty of pathological analysis of maternal tissues in the period following viral infection and prior to miscarriage. In this study, we predicted the occurrence of miscarriage by monitoring serum progesterone levels and performed pathological analysis of peri-placental tissues at a time point assumed to be just before miscarriage. This is the first report of trophoblast degeneration prior to miscarriage, suggesting that the experimental method used here is useful for analyzing the pathogenesis of virus infection-related miscarriage. Further immunostaining revealed that ZIKV NS1 was distributed not only in the uterus but also in the ovaries, with particularly pronounced staining of oocytes. Whether ZIKV infection affects female reproductive function should be clarified in the future.

  • Open Access

    The potential of a universal influenza virus-like particle vaccine expressing a chimeric cytokine

    by Kuniaki Nerome, Toshifumi Imagawa, Shigeo Sugita, Youta Arasaki, Kenichi Maegawa, Kazunori Kawasaki, Tsuyoshi Tanaka, Shinji Watanabe, Hidekazu Nishimura, Tetsuro Suzuki, et al.

    The efficacy of the current influenza vaccines is frequently reduced because of antigenic drift, a trade-off of developing improved vaccines with broad cross-protective activity against influenza A viruses. In this study, we have successfully constructed a chimeric cytokine (CC) comprising the M2 protein, influenza A neuraminidase stalk, and interleukin-12. We produced virus-like particles (VLPs) containing CC and influenza hemagglutinin (HA) proteins using a baculovirus system in Eri silkworm pupae. The protective efficacy of the CCHA-VLP vaccine was evaluated in mice. The CCFkH5HA-VLP vaccine increased the survival rates of BALB/c mice, infected with a lethal dose of PRH1 and HKH5 viruses, to 80% and 100%, respectively. The results suggested that CCHA-VLP successfully induced potent cross-reactive protective immunity against infection with homologous and heterologous subtypes of the influenza A virus. This is the first study to design a CC-containing HA-VLP vaccine and validate its protective efficacy.